ExoStemTech
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- $12M
Investors
- 5
About ExoStemTech
Founded in 2016 and headquartered in Ansan, South Korea, ExoStemTech focuses on exosome technology for therapeutic applications in regenerative medicine. The company was established by Yong-woo Cho, who has a history in biopharmaceutical ventures.ExoStemTech specializes in the production of exosomes derived from adult stem cells, along with functional exosomes that possess enhanced therapeutic efficacy. Their core offerings include proprietary therapeutics branded as CARTISOME®, BEIGESOME®, EST-T-EXO, OSTEOSOME®, HEPATOSOME®, and HYPOXISOME®, targeting conditions such as osteoarthritis, obesity, diabetes, liver disease, and cancer.ExoStemTech’s revenue model focuses on the commercialization of its exosome-based therapeutics through direct sales to healthcare providers, research institutions, and pharmaceutical partners. The company engages in B2B transactions, supplying hospitals and clinics with its flagship products for treatment protocols, especially in regenerative medicine and chronic disease management. Future growth strategies include launching upcoming products designed to enhance treatment efficacy and expanding into new geographic markets, specifically targeting regions with increasing demand for advanced therapeutic solutions. The company aims to advance its presence in Asia, Europe, and North America by the end of 2025.
Who invested in ExoStemTech
5 investors across 2 rounds
See all investors in ExoStemTech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ExoStemTech
Who invested in ExoStemTech?
ExoStemTech has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ExoStemTech raised?
ExoStemTech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ExoStemTech last raise money?
ExoStemTech's most recent round on record is a Series B, in Oct 2021.
What does ExoStemTech do?
Founded in 2016 and headquartered in Ansan, South Korea, ExoStemTech focuses on exosome technology for therapeutic applications in regenerative medicine.
Where is ExoStemTech headquartered?
ExoStemTech is headquartered in Ansan, South Korea.
Which VCs invest in companies like ExoStemTech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ExoStemTech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ExoStemTech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.